BLRX

BioLineRX
BLRX

Overview Fund Activity

26 hedge funds and large institutions have $1.99M invested in BioLineRX in 2022 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 7 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
26
Holders Change
-4
Holders Change %
-13.33%
% of All Funds
0.41%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
6
Reduced
7
Closed
6
Calls
$37K
Puts
$29K
Net Calls
+$8K
Net Calls Change
+$55K

Top Buyers

1
AWM
1
Apollon Wealth Management
South Carolina
$96K
2
Renaissance Technologies
2
Renaissance Technologies
New York
$115K
3
Morgan Stanley
3
Morgan Stanley
New York
$464K
4
GWM
4
Geneos Wealth Management
Colorado
$56K
5
Osaic Holdings
5
Osaic Holdings
Arizona
$31K

Top Sellers

1
AIM
1
ARK Investment Management
Florida
$0
2
PHP
2
Parkman Healthcare Partners
Connecticut
$463K
3
Envestnet Asset Management
3
Envestnet Asset Management
Illinois
$118K
4
JF
4
Jump Financial
Illinois
$0
5
Susquehanna International Group
5
Susquehanna International Group
Pennsylvania
$60K
Name Holding Trade Value Shares
Change 		Shares
Change %
AIM
26
ARK Investment Management
Florida
– -$2.16M -26,493 Closed
JF
27
Jump Financial
Illinois
– -$69K -848 Closed
GPFA
28
Game Plan Financial Advisors
Ohio
– -$37K -450 Closed
Marshall Wace
29
Marshall Wace
United Kingdom
– -$29K -363 Closed
EGM
30
Engineers Gate Manager
New York
– -$22K -269 Closed
AAS
31
Ameritas Advisory Services
Nebraska
– -$21K -261 Closed
1
2